Micron is an Atlanta-based company whose MAP technology was initially developed in Dr. Mark Prausnitz's labs at Georgia Tech. Micron has further developed the technology and emerged as a leader in the field of dissolvable microarray-based, drug and vaccine delivery technology.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 11/28/22 | $14,000,000 | Series A |
Global Health Investment Fund GRA Venture Fund LTS Lohmann | undisclosed |
| 05/10/23 | $3,000,000 | Series A Extension |
J2 Ventures | undisclosed |
